| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |